114 related articles for article (PubMed ID: 17762529)
1. Interference of factor V Leiden on protein S activity: evaluation of a new prothrombin time-based assay.
Tripodi A; Asti D; Chantarangkul V; Biguzzi E; Mannucci PM
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):543-6. PubMed ID: 17762529
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
3. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
[TBL] [Abstract][Full Text] [Related]
4. Apixaban Does Not Interfere With Protein S or Activated Protein C Resistance (Factor V Leiden) Testing Using aPTT-Based Methods.
Maryamchik E; Van Cott EM
Arch Pathol Lab Med; 2020 Nov; 144(11):1401-1407. PubMed ID: 32101451
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden).
Maryamchik E; Rosenbaum MW; Van Cott EM
Arch Pathol Lab Med; 2018 Jan; 142(1):70-74. PubMed ID: 28920711
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study.
van Dunné FM; de Craen AJ; Heijmans BT; Helmerhorst FM; Westendorp RG
Hum Reprod; 2006 Apr; 21(4):967-71. PubMed ID: 16439508
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the factor V Leiden paradox.
van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new venom-based clotting assay of protein C.
Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
[TBL] [Abstract][Full Text] [Related]
10. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
De Bel AV; Van der Cruyssen GA; Devreese KM
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
[TBL] [Abstract][Full Text] [Related]
11. Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease.
Haapaniemi E; Helenius J; Jakovljević D; Soinne L; Syrjälä M; Kaste M; Lassila R; Tatlisumak T
Thromb Haemost; 2009 Jan; 101(1):145-50. PubMed ID: 19132201
[TBL] [Abstract][Full Text] [Related]
12. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
13. Quality assurance issues and interpretation of assays.
Mackie I; Cooper P; Kitchen S
Semin Hematol; 2007 Apr; 44(2):114-25. PubMed ID: 17433904
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilic mutations in pre-eclampsia and pregnancy-induced hypertension.
Omar SZ; Qvist R; Khaing SL; Muniandy S; Bhalla S
J Obstet Gynaecol Res; 2008 Apr; 34(2):174-8. PubMed ID: 18412778
[TBL] [Abstract][Full Text] [Related]
15. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
[TBL] [Abstract][Full Text] [Related]
16. SV-IV Peptide1-16 reduces coagulant power in normal Factor V and Factor V Leiden.
Di Micco B; Lepretti M; Rota L; Quaglia I; Ferrazzi P; Di Micco G; Di Micco P
J Transl Med; 2007 Dec; 5():69. PubMed ID: 18154667
[TBL] [Abstract][Full Text] [Related]
17. Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism.
Kovacs MJ; Kovacs J; Anderson J; Rodger MA; Mackinnon K; Wells PS
Clin Lab Haematol; 2006 Feb; 28(1):9-13. PubMed ID: 16430453
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
19. Association between factor V Leiden mutation and coronary artery disease in the northeast region of Turkey.
Gurlertop HY; Gundogdu F; Pirim I; Islamoglu Y; Egerci N; Sevimli S; Erdem F; Senocak H
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):719-22. PubMed ID: 17982311
[TBL] [Abstract][Full Text] [Related]
20. Analytical considerations for free protein S assays in protein S deficiency.
Persson KE; Hillarp A; Dahlbäck B
Thromb Haemost; 2001 Nov; 86(5):1144-7. PubMed ID: 11816698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
